EUVIMEDOpdag EUVIMED
Crossref

Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium

Naokatsu Ando iD, Daisuke Mizushima iD, Misao Takano, Morika Mitobe, Kai Kobayashi, Hiroaki Kubota iD, Hirofumi Miyake, Jun Suzuki, Kenji Sadamasu, Takahiro Aoki, Koji Watanabe iD, Shinichi Oka and 1 more

Journal of Antimicrobial Chemotherapy · 2025-01-03 · 80 (1) · 247-253

DOI: 10.1093/jac/dkae403 ↗

At a glance

Journal article in Journal of Antimicrobial Chemotherapy, published online on 2024-11-05. Written by Naokatsu Ando and 12 co-authors. Institution: AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan. Major MEDLINE topics: Mycoplasma genitalium, Mycoplasma Infections, Anti-Bacterial Agents, Fluoroquinolones. Cited 9 times so far (Crossref); 36 references. Funded by: National Center for Global Health and Medicine.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Mycoplasma genitalium, which causes sexually transmitted diseases, is increasingly resistant to key antibiotics such as macrolides and quinolones, posing a challenge for treatment.

Objectives

To assess the effectiveness of prolonged sitafloxacin and doxycycline combination therapy as a new alternative treatment strategy for highly drug-resistant M. genitalium strains Methods A prospective cohort study was conducted at the National Center for Global Health and Medicine, Tokyo, Japan, from 1 January 2020 to 31 October 2022. Patients with M. genitalium urogenital or rectal infections and those who did not receive the initial sitafloxacin monotherapy were included. Patients were administered sitafloxacin and doxycycline for 21 days as salvage therapy. M. genitalium isolates were tested for parC, gyrA and 23S rRNA resistance-associated mutations.

Results

Twenty-seven patients received the combination therapy. All M. genitalium strains available for resistance analysis had parC (24/24) and macrolide resistance-associated (25/25) mutations, and 68% (17/25) had gyrA mutations. The overall cure rate was 77.8%. For strains with concurrent parC and gyrA mutations, the cure rate was 68.8% (P = 0.053) compared with that for monotherapy (37.5%).

Conclusions

Prolonged combination therapy is highly effective against M. genitalium strains with concurrent parC and gyrA mutations. Future research should focus on establishing the optimal treatment duration and monitoring the risk of resistance.

Subjects

MeSH terms (MEDLINE)

Mycoplasma genitaliumMycoplasma InfectionsAnti-Bacterial AgentsFluoroquinolonesDrug Therapy, CombinationDoxycyclineDNA Topoisomerase IVDNA GyraseHumansFemaleMaleProspective StudiesAdultMiddle AgedMicrobial Sensitivity TestsMutationRNA, Ribosomal, 23SDrug Resistance, BacterialTreatment Outcome

Substances

sitafloxacinAnti-Bacterial AgentsFluoroquinolonesDoxycyclineDNA Topoisomerase IVDNA GyraseRNA, Ribosomal, 23S

Authors and institutions

  • AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Department of Microbiology, Tokyo Metropolitan Institute for Public Health, Tokyo, Japan.

ORCID profiles: Naokatsu Ando, Daisuke Mizushima, Hiroaki Kubota, Koji Watanabe

Funding

  • National Center for Global Health and Medicine

Cite

APA

Ando, N., Mizushima, D., Takano, M., Mitobe, M., Kobayashi, K., Kubota, H., Miyake, H., Suzuki, J., Sadamasu, K., Aoki, T., Watanabe, K., Oka, S., & Gatanaga, H. (2025). Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium. Journal of Antimicrobial Chemotherapy, 80(1), 247-253. https://doi.org/10.1093/jac/dkae403

Vancouver

Ando N, Mizushima D, Takano M, Mitobe M, Kobayashi K, Kubota H, et al. Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium. Journal of Antimicrobial Chemotherapy. 2025;80(1):247-253. doi:10.1093/jac/dkae403

BibTeX
@article{Ando2025,
  author = {Ando, Naokatsu and Mizushima, Daisuke and Takano, Misao and Mitobe, Morika and Kobayashi, Kai and Kubota, Hiroaki and Miyake, Hirofumi and Suzuki, Jun and Sadamasu, Kenji and Aoki, Takahiro and Watanabe, Koji and Oka, Shinichi and Gatanaga, Hiroyuki},
  title = {Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {1},
  pages = {247--253},
  doi = {10.1093/jac/dkae403}
}
Start for free →